MAVENCLAD (cladribine)


Drug overview for MAVENCLAD (cladribine):

Generic name: cladribine (KLAD-ri-been)
Drug class: Purine Analogues
Therapeutic class: Multiple Sclerosis Agents

Cladribine, a purine nucleoside antimetabolite, has immunomodulatory and disease-modifying activity in multiple sclerosis (MS);

No enhanced Uses information available for this drug.
DRUG IMAGES
  • No Image Available
    No Image Available
The following indications for MAVENCLAD (cladribine) have been approved by the FDA:

Indications:
Relapsing form of multiple sclerosis


Professional Synonyms:
Multiple sclerosis, relapsing form